Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
Gianluca Dini(University of Perugia), Alberto Verrottı(University of Perugia), Eleonora Tulli(University of Perugia), Giuseppe Di Cara(University of Perugia), Pasquale Striano(Great Ormond Street Hospital), Giovanni Battista Dell’Isola(Vita-Salute San Raffaele University), Elisabetta Mencaroni(University of Perugia)
Cited by 17
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Autism Spectrum Disorders and the Gut Microbiota
|Nutrients|2019|479
The Pharmacoresistant Epilepsy: An Overview on Existent and New Emerging Therapies
|Frontiers in Neurology|2021|260
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
|Nature Communications|2019|249
Microbiota-gut brain axis involvement in neuropsychiatric disorders
|Expert Review of Neurotherapeutics|2019|177